Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. [electronic resource]
Producer: 20001222Description: 999-1005 p. digitalISSN:- 1524-4571
- Angiotensin Receptor Antagonists
- Animals
- Antihypertensive Agents -- pharmacology
- Aorta -- drug effects
- Biphenyl Compounds -- pharmacology
- Cell Adhesion Molecules -- metabolism
- Cyclic GMP -- metabolism
- Endothelium, Vascular -- drug effects
- Enzyme Inhibitors -- pharmacology
- Hyperlipidemias -- genetics
- In Vitro Techniques
- Irbesartan
- Microfilament Proteins
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase -- metabolism
- Nitric Oxide Synthase Type III
- Nitroarginine -- pharmacology
- Oxidative Stress -- drug effects
- Phosphoproteins -- metabolism
- Phosphorylation -- drug effects
- Rabbits
- Receptor, Angiotensin, Type 1
- Receptor, Angiotensin, Type 2
- Serine -- metabolism
- Signal Transduction -- drug effects
- Superoxide Dismutase -- metabolism
- Tetrazoles -- pharmacology
- Vasodilation -- drug effects
- Vasodilator Agents -- pharmacology
- Vasodilator-Stimulated Phosphoprotein
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.